Free Trial

BioLargo (BLGO) Competitors

BioLargo logo
$0.20 +0.01 (+5.21%)
As of 08/22/2025 03:36 PM Eastern

BLGO vs. AMTX, VGAS, FSI, TSE, ORGN, ALTO, LODE, ZTEK, LOOP, and LNZA

Should you be buying BioLargo stock or one of its competitors? The main competitors of BioLargo include Aemetis (AMTX), Verde Clean Fuels (VGAS), Flexible Solutions International (FSI), Trinseo (TSE), Origin Materials (ORGN), Alto Ingredients (ALTO), Comstock (LODE), Zentek (ZTEK), Loop Industries (LOOP), and LanzaTech Global (LNZA). These companies are all part of the "chemicals" industry.

BioLargo vs. Its Competitors

Aemetis (NASDAQ:AMTX) and BioLargo (NASDAQ:BLGO) are both small-cap chemicals companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

27.0% of Aemetis shares are owned by institutional investors. Comparatively, 0.0% of BioLargo shares are owned by institutional investors. 14.7% of Aemetis shares are owned by company insiders. Comparatively, 19.3% of BioLargo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, BioLargo's average media sentiment score of 1.94 beat Aemetis' score of 1.90 indicating that BioLargo is being referred to more favorably in the news media.

Company Overall Sentiment
Aemetis Very Positive
BioLargo Very Positive

Aemetis currently has a consensus target price of $17.00, indicating a potential upside of 569.29%. Given Aemetis' stronger consensus rating and higher probable upside, research analysts plainly believe Aemetis is more favorable than BioLargo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aemetis
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
BioLargo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Aemetis has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, BioLargo has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500.

BioLargo has a net margin of -11.45% compared to Aemetis' net margin of -36.70%. Aemetis' return on equity of 0.00% beat BioLargo's return on equity.

Company Net Margins Return on Equity Return on Assets
Aemetis-36.70% N/A -33.18%
BioLargo -11.45%-39.90%-22.06%

BioLargo has lower revenue, but higher earnings than Aemetis. BioLargo is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aemetis$267.64M0.60-$87.54M-$1.62-1.57
BioLargo$12.23M4.99-$3.50M-$0.01-19.80

Summary

Aemetis beats BioLargo on 8 of the 15 factors compared between the two stocks.

Get BioLargo News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLGO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLGO vs. The Competition

MetricBioLargoChemicals & allied products IndustryConstruction SectorNASDAQ Exchange
Market Cap$61.02M$11.86B$9.60B$9.76B
Dividend YieldN/A1.09%1.85%4.06%
P/E Ratio-19.80N/A16.3826.05
Price / Sales4.993.58121.4288.42
Price / CashN/A14.8015.4059.36
Price / Book19.8011.344.816.60
Net Income-$3.50M$989.69M$618.69M$265.65M
7 Day Performance11.86%5.93%6.54%2.00%
1 Month Performance8.08%4.04%9.69%0.46%
1 Year Performance-13.23%-6.62%104.22%18.88%

BioLargo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLGO
BioLargo
0.5157 of 5 stars
$0.20
+5.2%
N/A-13.2%$61.02M$12.23M-19.8030Positive News
AMTX
Aemetis
2.25 of 5 stars
$2.36
-4.1%
$17.00
+620.3%
-3.8%$155.57M$267.64M-1.46160
VGAS
Verde Clean Fuels
0.1896 of 5 stars
$2.55
flat
N/A-22.1%$113.60MN/A-6.222Positive News
Gap Up
FSI
Flexible Solutions International
3.7597 of 5 stars
$8.00
+1.8%
N/A+150.3%$101.18M$37.32M24.2440News Coverage
Analyst Revision
TSE
Trinseo
1.4903 of 5 stars
$2.34
-2.7%
N/A-41.2%$86.29M$3.51B-0.212,950Positive News
ORGN
Origin Materials
1.947 of 5 stars
$0.52
-3.8%
$1.50
+188.9%
-62.6%$80.89M$31.28M-0.84160
ALTO
Alto Ingredients
3.2167 of 5 stars
$1.03
-1.9%
$5.50
+434.0%
-26.9%$80.44M$965.26M-1.12420Positive News
LODE
Comstock
1.3972 of 5 stars
$2.26
-3.8%
$4.00
+77.0%
+29.9%$80.19M$3.38M-18.8330Analyst Revision
ZTEK
Zentek
0.3268 of 5 stars
$0.72
-2.4%
N/A-28.0%$77.23M$1.22M-14.4024News Coverage
Short Interest ↑
LOOP
Loop Industries
1.7592 of 5 stars
$1.48
-3.9%
N/A+1.6%$73.49M$10.89M-5.2990Short Interest ↑
LNZA
LanzaTech Global
1.66 of 5 stars
$19.72
-10.4%
$2.00
-89.9%
-87.2%$51.06M$49.59M-29.433News Coverage
Analyst Downgrade
Stock Split
Short Interest ↑
Analyst Revision

Related Companies and Tools


This page (NASDAQ:BLGO) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners